Business
IB Software Chosen by LA County Hospital
IB Software Chosen by LA County Hospital.
About this update from Imaging Biometrics Limited
[{"type":"text","content":"\n \n \n \n RNS Number : 8017A\n IQ-AI Limited\n 04 June 2021\n \n \n \n \n 4 June 2021\n \n \n IQ-AI Ltd\n \n \n (\"IQ-AI\" or the \"Company\")\n \n \n IB Software Chosen by LA County Hospital \n \n \n Imaging Biometrics®, LLC (\"IB\"), a subsidiary of IQ-AI Limited (LON:IQAI), announced today that Los Angeles County Hospital (LAC) has purchased IB Clinic. Following the recent installation at the Keck Medical Center of USC, the purchase further extends IB's exclusive quantitative imaging capabilities throughout the entire USC and LA County Hospital network; the hub in the County-run healthcare system which serves over 10 million residents. \n \n \n The automated generation of IB's quantitative parameter maps are ideal for high-volume brain tumour centers such as USC/LAC. Within seconds after acquiring the MR data from the scanner, IB's quantitative output is available for diagnostic review. The unattended processing offloads busy radiology departments, including MR technologists and neuro radiologists, and fosters more productive workflows. More importantly, the standardised output of IB's software is independent of scanner, field strength, patient or timepoint. Therefore, direct comparison of tumour volumes can be made regardless of when or where a patient is scanned. \n \n \n Another ancillary benefit of IB's brain tumour imaging platform is that it helps drive a more consistent language for the entire treatment team. The quantitative output provides objective and consistent terminology that is shared by radiologists, oncologists, surgeons, and the patients they serve.\n \n \n \"IB has been in the center of long-standing collaborative efforts focused on standardising the acquisition and post-processing of brain tumour imaging protocols across healthcare. This purchase by LAC underscores the progress made towards this goal, and we look forward to working with other cancer centers interested in our approach,\" said Michael Schmainda, CEO of IB.\n \n \n The Directors of the Company accept responsibility for the contents of this announcement.\n \n -ENDS-\n \n For further information, please contact:\n \n \n \n IQ-AI Limited\n Trevor Brown/Vinod Kaushal/Qu Li\n Tel: 020 7469 0930\n \n \n \n \n Peterhouse Capital Limited (Financial Adviser and Broker)\n Lucy Williams/Mark Anwyl\n Tel: 020 7220 9797\n \n \n \...